• LAST PRICE
    110.1750
  • TODAY'S CHANGE (%)
    Trending Up0.1350 (0.1227%)
  • Bid / Lots
    110.0600/ 8
  • Ask / Lots
    110.4100/ 8
  • Open / Previous Close
    109.1400 / 110.0400
  • Day Range
    Low 108.1100
    High 110.6324
  • 52 Week Range
    Low 51.2100
    High 115.5300
  • Volume
    24,629
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 110.04
TimeVolumeLGND
09:32 ET901109.14
09:35 ET100108.505
09:39 ET300108.5
09:50 ET208108.38
09:57 ET100108.37
10:00 ET100108.59
10:02 ET100109.135
10:04 ET3035108.11
10:06 ET100108.485
10:08 ET200108.545
10:09 ET100109.17
10:18 ET200109.285
10:20 ET100109.435
10:26 ET100109.45
10:27 ET2602110.02
10:31 ET100110.2
10:33 ET813110.28
10:38 ET100110.325
10:42 ET100110.315
10:51 ET442110.445
10:54 ET100110.445
11:00 ET500110.2
11:02 ET100109.95
11:07 ET206109.53
11:12 ET200109.955
11:18 ET100110.37
11:20 ET100109.98
11:21 ET100110.095
11:25 ET200110.125
11:27 ET100110.13
11:34 ET200110.045
11:41 ET100109.625
11:43 ET200109.7
11:50 ET100109.34
12:01 ET450109.45
12:21 ET200109.505
12:24 ET206109.72
12:30 ET400110.1
12:39 ET100110.175
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLGND
Ligand Pharmaceuticals Inc
2.0B
49.5x
-12.71%
United StatesHROW
Harrow Inc
1.6B
-49.0x
---
United StatesOCUL
Ocular Therapeutix Inc
1.6B
-9.6x
---
United StatesIMCR
Immunocore Holdings PLC
1.6B
-29.3x
---
United StatesAVDL
Avadel Pharmaceuticals PLC
1.4B
-12.8x
---
United StatesEOLS
Evolus Inc
1.1B
-18.1x
---
As of 2024-11-04

Company Information

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several United States Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. Its technologies also include HepDirect, LTP and BEPro Technology Platform, SUREtechnology Platform (owned by Selexis), and Pelican Expression Technology. It has established multiple alliances, licenses and other business relationships with various pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International.

Contact Information

Headquarters
555 Heritage Drive, Suite 200JUPITER, FL, United States 33458
Phone
858-550-7500
Fax
302-636-5454

Executives

Independent Chairman of the Board
John Kozarich
Chief Executive Officer, Director
Todd Davis
Chief Financial Officer
Octavio Espinoza
Chief Legal Officer
Andrew Reardon
Independent Director
Jason Aryeh

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.0B
Revenue (TTM)
$133.5M
Shares Outstanding
18.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.03
EPS
$2.22
Book Value
$39.92
P/E Ratio
49.5x
Price/Sales (TTM)
15.1
Price/Cash Flow (TTM)
26.0x
Operating Margin
-14.53%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.